Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1997; 90(Suppl 31): 13–20.
PMCID: PMC1296093

Joint disorders in cystic fibrosis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Phillips BM, David TJ. Pathogenesis and management of arthropathy in cystic fibrosis. J R Soc Med. 1986;79 (Suppl 12):44–50. [PMC free article] [PubMed]
  • Hodson ME. Vasculitis and arthropathy in cystic fibrosis. J R Soc Med. 1992;85 (Suppl 19):38–40. [PMC free article] [PubMed]
  • Johnson S, Knox AJ. Arthropathy in cystic fibrosis. Respir Med. 1994 Sep;88(8):567–570. [PubMed]
  • Dickinson CJ. The aetiology of clubbing and hypertrophic osteoarthropathy. Eur J Clin Invest. 1993 Jun;23(6):330–338. [PubMed]
  • Dixey J, Redington AN, Butler RC, Smith MJ, Batchelor JR, Woodrow DF, Hodson ME, Batten JC, Brewerton DA. The arthropathy of cystic fibrosis. Ann Rheum Dis. 1988 Mar;47(3):218–223. [PMC free article] [PubMed]
  • Rush PJ, Shore A, Coblentz C, Wilmot D, Corey M, Levison H. The musculoskeletal manifestations of cystic fibrosis. Semin Arthritis Rheum. 1986 Feb;15(3):213–225. [PubMed]
  • Pineda C. Diagnostic imaging in hypertrophic osteoarthropathy. Clin Exp Rheumatol. 1992 May-Jun;10 (Suppl 7):27–33. [PubMed]
  • Bourke S, Rooney M, Fitzgerald M, Bresnihan B. Episodic arthropathy in adult cystic fibrosis. Q J Med. 1987 Aug;64(244):651–659. [PubMed]
  • Pertuiset E, Menkes CJ, Lenoir G, Jehanne M, Douchain F, Guillot M. Cystic fibrosis arthritis. A report of five cases. Br J Rheumatol. 1992 Aug;31(8):535–538. [PubMed]
  • Wulffraat NM, de Graeff-Meeder ER, Rijkers GT, van der Laag H, Kuis W. Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis. J Pediatr. 1994 Sep;125(3):374–378. [PubMed]
  • Soden M, Tempany E, Bresnihan B. Sarcoid arthropathy in cystic fibrosis. Br J Rheumatol. 1989 Aug;28(4):341–343. [PubMed]
  • Benjamin CM, Clague RB. Psoriatic or cystic fibrosis arthropathy? Difficulty with diagnosis and management. Br J Rheumatol. 1990 Aug;29(4):301–302. [PubMed]
  • Finnegan MJ, Hinchcliffe J, Russell-Jones D, Neill S, Sheffield E, Jayne D, Wise A, Hodson ME. Vasculitis complicating cystic fibrosis. Q J Med. 1989 Jul;72(267):609–621. [PubMed]
  • Fradin MS, Kalb RE, Grossman ME. Recurrent cutaneous vasculitis in cystic fibrosis. Pediatr Dermatol. 1987 Aug;4(2):108–111. [PubMed]
  • Garty BZ, Scanlin T, Goldsmith DP, Grunstein M. Cutaneous manifestations of cystic fibrosis: possible role of cryoglobulins. Br J Dermatol. 1989 Nov;121(5):655–658. [PubMed]
  • Schidlow DV, Panitch HB, Zaeri N, Zenel J, Alpert BE. Purpuric rashes in cystic fibrosis. Am J Dis Child. 1989 Sep;143(9):1030–1032. [PubMed]
  • Szer IS. Henoch-Schönlein purpura. Curr Opin Rheumatol. 1994 Jan;6(1):25–31. [PubMed]
  • Gross WL, Csernok E. Immunodiagnostic and pathophysiologic aspects of antineutrophil cytoplasmic antibodies in vasculitis. Curr Opin Rheumatol. 1995 Jan;7(1):11–19. [PubMed]
  • Schaad UB, abdus Salam M, Aujard Y, Dagan R, Green SD, Peltola H, Rubio TT, Smith AL, Adam D. Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J. 1995 Jan;14(1):1–9. [PubMed]
  • Stahlmann R, Förster C, Shakibaei M, Vormann J, Günther T, Merker HJ. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob Agents Chemother. 1995 Sep;39(9):2013–2018. [PMC free article] [PubMed]
  • Stahlmann R, Merker HJ, Hinz N, Chahoud I, Webb J, Heger W, Neubert D. Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch Toxicol. 1990;64(3):193–204. [PubMed]
  • Lomaestro BM, Bailie GR. Quinolone-cation interactions: a review. DICP. 1991 Nov;25(11):1249–1258. [PubMed]
  • Kubin R. Safety and efficacy of ciprofloxacin in paediatric patients--review. Infection. 1993 Nov-Dec;21(6):413–421. [PubMed]
  • Pertuiset E, Lenoir G, Jehanne M, Douchain F, Guillot M, Menkès CJ. Tolérance articulaire de la péfloxacine et de l'ofloxacine chez les enfants et adolescents atteints de mucoviscidose. Rev Rhum Mal Osteoartic. 1989 Nov;56(11):735–740. [PubMed]
  • Samuelson WM, Pleasants RA, Whitaker MS. Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient. Ann Pharmacother. 1993 Mar;27(3):302–303. [PubMed]
  • Danisovicová A, Brezina M, Belan S, Kayserová H, Kaiserová E, Hruskovic I, Orosová K, Dluholucký S, Galova K, Mathéova E, et al. Magnetic resonance imaging in children receiving quinolones: no evidence of quinolone-induced arthropathy. A multicenter survey. Chemotherapy. 1994 May-Jun;40(3):209–214. [PubMed]
  • Schaad UB, Stoupis C, Wedgwood J, Tschaeppeler H, Vock P. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr Infect Dis J. 1991 Oct;10(10):723–729. [PubMed]
  • Aricò M, Bossi G, Caselli D, Cosi G, Villa A, Beluffi G, Genovese E. Long-term magnetic resonance survey of cartilage damage in leukemic children treated with fluoroquinolones. Pediatr Infect Dis J. 1995 Aug;14(8):713–714. [PubMed]
  • Barland P, Lipstein E. Selection and use of laboratory tests in the rheumatic diseases. Am J Med. 1996 Feb 26;100(2A):16S–23S. [PubMed]
  • Burmester GR, Daser A, Kamradt T, Krause A, Mitchison NA, Sieper J, Wolf N. Immunology of reactive arthritides. Annu Rev Immunol. 1995;13:229–250. [PubMed]
  • Hodson ME, Beldon I, Batten JC. Circulating immune complexes in patients with cystic fibrosis in relation to clinical features. Clin Allergy. 1985 Jul;15(4):363–370. [PubMed]
  • Disis ML, McDonald TL, Colombo JL, Kobayashi RH, Angle CR, Murray S. Circulating immune complexes in cystic fibrosis and their correlation to clinical parameters. Pediatr Res. 1986 May;20(5):385–390. [PubMed]
  • Wisnieski JJ, Todd EW, Fuller RK, Jones PK, Dearborn DG, Boat TF, Naff GB. Immune complexes and complement abnormalities in patients with cystic fibrosis. Increased mortality associated with circulating immune complexes and decreased function of the alternative complement pathway. Am Rev Respir Dis. 1985 Oct;132(4):770–776. [PubMed]
  • Moss RB, Hsu YP, Lewiston NJ, Curd JG, Milgrom H, Hart S, Dyer B, Larrick JW. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis. Am Rev Respir Dis. 1986 Apr;133(4):648–652. [PubMed]
  • Manthei U, Taussig LM, Beckerman RC, Strunk RC. Circulating immune complexes in cystic fibrosis. Am Rev Respir Dis. 1982 Aug;126(2):253–257. [PubMed]
  • Pitcher-Wilmott RW, Levinsky RJ, Matthew DJ. Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis. Arch Dis Child. 1982 Aug;57(8):577–581. [PMC free article] [PubMed]
  • Church JA, Jordan SC, Keens TG, Wang CI. Circulating immune complexes in patients with cystic fibrosis. Chest. 1981 Oct;80(4):405–411. [PubMed]
  • Jones MM, Seilheimer DK, Pollack MS, Curry M, Crane MM, Rossen RD. Relationship of hypergammaglobulinemia, circulating immune complexes, and histocompatibility antigen profiles in patients with cystic fibrosis. Am Rev Respir Dis. 1989 Dec;140(6):1636–1639. [PubMed]
  • Abman SH, Ogle JW, Harbeck RJ, Butler-Simon N, Hammond KB, Accurso FJ. Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. J Pediatr. 1991 Aug;119(2):211–217. [PubMed]
  • Davis CA, Abramowsky CR, Swinehart G. Circulating immune complexes and the nephropathy of cystic fibrosis. Hum Pathol. 1984 Mar;15(3):244–247. [PubMed]
  • Tomashefski JF, Jr, Abramowsky CR, Chung-Park M, Wisniewska J, Bruce MC. Immunofluorescence studies of lung tissue in cystic fibrosis. Pediatr Pathol. 1992 May-Jun;12(3):313–324. [PubMed]
  • Pope RM. Rheumatoid arthritis: pathogenesis and early recognition. Am J Med. 1996 Feb 26;100(2A):3S–9S. [PubMed]
  • Coffey M, Hassan J, Feighery C, Fitzgerald M, Bresnihan B. Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections. Clin Exp Immunol. 1989 Jul;77(1):52–57. [PubMed]
  • Keogan MT, Callaghan M, Yanni G, Mulherin D, Feighery C, Brown DL, Fitzgerald MX, Bresnihan B. Spontaneous in vitro production of rheumatoid factor during infectious exacerbations of cystic fibrosis: correlation with circulating immune complex levels. Clin Exp Immunol. 1993 Mar;91(3):462–466. [PubMed]
  • Careless DJ, Inman RD. Etiopathogenesis of reactive arthritis and ankylosing spondylitis. Curr Opin Rheumatol. 1995 Jul;7(4):290–298. [PubMed]
  • Burmester GR, Daser A, Kamradt T, Krause A, Mitchison NA, Sieper J, Wolf N. Immunology of reactive arthritides. Annu Rev Immunol. 1995;13:229–250. [PubMed]
  • Cid MC. New developments in the pathogenesis of systemic vasculitis. Curr Opin Rheumatol. 1996 Jan;8(1):1–11. [PubMed]
  • Calabrese LH, Duna GF. Evaluation and treatment of central nervous system vasculitis. Curr Opin Rheumatol. 1995 Jan;7(1):37–44. [PubMed]
  • Exley AR, Bacon PA. Clinical disease activity in systemic vasculitis. Curr Opin Rheumatol. 1996 Jan;8(1):12–18. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press